support@nanobiousa.com
1-888-678-8889 (USA)
| Product Name | Size | Catalog No. |
|---|---|---|
3WJ-RFA(TNBC)-antiMIR19Serum stable 3WJ RNA Nanoparticle with an aptamer targeting Triple Negative Breast Cancer (TNBC) cells and antiMIR19 |
1nmol | RNP-M19-01-1 |
| 50nmol | RNP-M19-01-2 | |
3WJ-RFA(PC)-antiMIR19Serum stable 3WJ RNA Nanoparticle with an aptamer targeting Prostate Cancer (PC) cells and antiMIR19 |
1nmol | RNP-M19-02-1 |
| 50nmol | RRNP-M19-02-2 | |
3WJ-RFA(HER2)-antiMIR19Serum stable 3WJ RNA Nanoparticle with an aptamer targeting HER2 + cancer cells and antiMIR19 |
1nmol | RNP-M19-03-1 |
| 50nmol | RNP-M19-03-2 | |
3WJ-RFA(EC)-antiMIR19Serum stable 3WJ RNA Nanoparticle with an aptamer targeting Epithelial Cancer (EC) cells and antiMIR19 |
1nmol | RNP-M19-04-1 |
| 50nmol | RNP-M19-04-2 | |
3WJ-RFC(FA)-antiMIR19Serum stable 3WJ RNA Nanoparticle with a folate ligand for targeting folate receptor (+) cells and antiMIR19 |
1nmol | RNP-M19-05-1 |
| 50nmol | RNP-M19-05-2 | |
3WJ-RFC(GL)-antiMIR19Serum stable 3WJ RNA Nanoparticle with a galactose ligand for targeting liver cancer cells and antiMIR19 |
1nmol | RNP-M19-06-1 |
| 50nmol | RNP-M19-06-2 | |
3WJ-RFM-antiMIR19Serum stable 3WJ RNA Nanoparticle with a mutant aptamer (serving as a targeting control) and antiMIR19 |
1nmol | RNP-M19-07-1 |
| 50nmol | RNP-M19-07-2 | |
3WJ-RF-antiMIR19Serum stable 3WJ RNA Nanoparticle without ligand (serving as vector control) but with antiMIR19 |
1nmol | RNP-M19-08-1 |
| 50nmol | RNP-M19-08-2 |
